High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes
D. Engelbertsen*, D. V. Anand, G. N. Fredrikson, David Hopkins, R. Corder, P. K. Shah, A. Lahiri, J. Nilsson, E. Bengtsson
Research output: Contribution to journal › Article › peer-review
28Citations
(Scopus)
Fingerprint
Dive into the research topics of 'High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes'. Together they form a unique fingerprint.